UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Macrophage activation syndrome and COVID-19

Inflammation and Regeneration, 2020-08, Vol.40 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

Interleukin‐34, a comprehensive review

Journal of leukocyte biology, 2018-11, Vol.104 (5), p.931-951

2018

Volltextzugriff (PDF)

IL-34, the rationale for its expression in physiological and pathological conditions

Seminars in immunology, 2021-04, Vol.54, p.101517-101517, Article 101517

2021

Volltextzugriff (PDF)

Interleukin 34, from pathogenesis to clinical applications

Cytokine (Philadelphia, Pa.), 2017-11, Vol.99, p.139-147

2017

Volltextzugriff (PDF)

Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13), p.2629-2640

2015

Volltextzugriff (PDF)

Studies on immune regulation for allogeneic iPSC-based transplantation

Inflammation and Regeneration, 2022-12, Vol.42 (1), p.65-65, Article 65

Seino, Ken-Ichiro

2022

Volltextzugriff (PDF)

Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells

International immunology, 2023-07, Vol.35 (7), p.327-338

2023

Volltextzugriff (PDF)

A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin

Oncoimmunology, 2023-12, Vol.12 (1), p.2238499-2238499

2023

Volltextzugriff (PDF)

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Cancer Immunology, Immunotherapy, 2023-04, Vol.72 (4), p.851-864

2023

Volltextzugriff (PDF)

Tumour resistance in induced pluripotent stem cells derived from naked mole-rats

Nature communications, 2016-05, Vol.7 (1), p.11471-9, Article 11471

2016

Volltextzugriff (PDF)

Interleukin-34 contributes to poor prognosis in triple-negative breast cancer

Breast cancer (Tokyo, Japan), 2020-11, Vol.27 (6), p.1198-1204

2020

Volltextzugriff (PDF)

Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation

Journal of radiation research, 2017-07, Vol.58 (4), p.446-455

2017

Volltextzugriff (PDF)

Immune reaction and regulation in transplantation based on pluripotent stem cell technology

Inflammation and Regeneration, 2020-07, Vol.40 (1), p.1-12, Article 12

2020

Volltextzugriff (PDF)

Blocking of oestrogen signals improves anti-tumour effect regardless of oestrogen receptor alpha expression in cancer cells

British journal of cancer, 2023-10, Vol.129 (6), p.935-946

2023

Volltextzugriff (PDF)

Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition

Journal for immunotherapy of cancer, 2023-11, Vol.11 (11), p.e006677

2023

Volltextzugriff (PDF)

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts

Transplantation, 2015-11, Vol.99 (11), p.2301-2310

2015

Volltextzugriff (PDF)

Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells

Oncoimmunology, 2023-12, Vol.12 (1), p.2213132-2213132

2023

Volltextzugriff (PDF)

Treg-enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts

Experimental dermatology, 2014-04, Vol.23 (4), p.266-271

2014

Volltextzugriff (PDF)

Functionally distinct NKT cell subsets and subtypes

The Journal of experimental medicine, 2005-12, Vol.202 (12), p.1623-1626

2005

Volltextzugriff (PDF)

Steps towards COVID-19 suppression

Inflammation and Regeneration, 2020-06, Vol.40 (1), p.13-13, Article 13

2020

Volltextzugriff (PDF)

Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model

Inflammation and Regeneration, 2022-02, Vol.42 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma

Inflammation and Regeneration, 2018-03, Vol.38 (1), p.3, Article 3

2018

Volltextzugriff (PDF)

Interleukin-34 cancels anti-tumor immunity by PARP inhibitor

Journal of Gynecologic Oncology, 2023, 34(3), , pp.1-16

2023

Volltextzugriff (PDF)

Natural killer T cell‐mediated antitumor immune responses and their clinical applications

Cancer science, 2006-09, Vol.97 (9), p.807-812

2006

Volltextzugriff (PDF)

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types

Frontiers in immunology, 2020-02, Vol.11, p.57-57

2020

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieScientific Reports

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(162)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Macrophage activation syndrome and COVID-19

Interleukin‐34, a comprehensive review

IL-34, the rationale for its expression in physiological and pathological conditions

Interleukin 34, from pathogenesis to clinical applications

Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer

Studies on immune regulation for allogeneic iPSC-based transplantation

Induction of allograft tolerance by adoptive transfer of donor B cells: an immune regulatory strategy for transplantation using MHC-matched iPS cells

A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Tumour resistance in induced pluripotent stem cells derived from naked mole-rats

Interleukin-34 contributes to poor prognosis in triple-negative breast cancer

Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation

Immune reaction and regulation in transplantation based on pluripotent stem cell technology

Blocking of oestrogen signals improves anti-tumour effect regardless of oestrogen receptor alpha expression in cancer cells

Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts

Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells

Treg-enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts

Functionally distinct NKT cell subsets and subtypes

Steps towards COVID-19 suppression

Evaluation of immunosuppression protocols for MHC-matched allogeneic iPS cell-based transplantation using a mouse skin transplantation model

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma

Interleukin-34 cancels anti-tumor immunity by PARP inhibitor

Natural killer T cell‐mediated antitumor immune responses and their clinical applications

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types

Aktive Filter

Suchergebnisse filtern